Skip to main content
Equibles
EOLS logo

EOLS · Evolus, Inc. · Webcasts, Transcripts & Audio

Track EOLS — free

Use EOLS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EOLS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.34 -0.18 (-2.40%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$496.70M
Shares
66.05M
Volume · Oct 30 793.61K Avg daily vol (3M) 892.94K

Evolus, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Evolus, Inc. (EOLS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Conference
Investor event
2026-11-11
Evolus, Inc. (EOLS) November 11, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-11
Evolus, Inc. (EOLS) November 11, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-11-04
Evolus, Inc. (EOLS) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript
Confident tone International Expansion and Partnerships Strategic Licensing and Pipeline (Profilo, Sculpt, Lips) Tariffs and Trade Policy
Revenue
$84.08M
▲ 21.2% YoY
Diluted EPS
$-0.12
Gross margin
68.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Evolus, Inc. (EOLS) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-04
Evolus, Inc. (EOLS) Q1 2026 Earnings Call Transcript
Confident tone International Expansion / Esteem Europe Launch Aesthetics Market Conditions Skulpt/Sculpt FDA Approval
Revenue
$73.14M
▲ 6.7% YoY
Diluted EPS
$-0.16
Gross margin
66.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript
Confident tone Evolysse filler launch and expansion International expansion Jeuveau U.S. market share gains
Revenue
$90.30M*
▲ 14.4% YoY
Gross margin
65.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript
Positive tone Evolysse product launch and adoption Jeuveau performance and market share Path to profitability and expense discipline
Revenue
$68.97M
▲ 12.9% YoY
Diluted EPS
$-0.24
Gross margin
66.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript
Cautious tone U.S. toxin market softness Evolysse launch 2025 guidance reset
Revenue
$69.39M
▲ 3.7% YoY
Diluted EPS
$-0.27
Gross margin
65.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript
Confident tone Evolysse launch momentum Tariff exposure and mitigation Toxin (Jeuveau) commercial performance
Revenue
$68.52M
▲ 15.5% YoY
Diluted EPS
$-0.30
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript
Confident tone Evolys Launch Profitability Jeuveau
Revenue
$78.95M*
▲ 29.4% YoY
Gross margin
66.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Evolus, Inc. (EOLS) Q3 2024 Earnings Call Transcript
Confident tone Evolysse / Estyme Filler Launch Revenue Growth & Market Outperformance Profitability Path
Revenue
$61.09M
▲ 22.1% YoY
Diluted EPS
$-0.30
Gross margin
68.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript
Confident tone Revenue growth and market share Filler pipeline (Evolysse / Athene) Aesthetic market dynamics and GLP impact
Revenue
$66.91M
▲ 35.6% YoY
Diluted EPS
$-0.18
Gross margin
70.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Evolus, Inc. (EOLS) Q1 2024 Earnings Call Transcript
Confident tone Jeuveau / Nuceiva Neurotoxin Business Long-Term Revenue Target Path to Profitability
Revenue
$59.33M
▲ 42.2% YoY
Diluted EPS
$-0.22
Gross margin
68.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-07
Evolus, Inc. (EOLS) Q4 2023 Earnings Call Transcript
Confident tone Path to profitability Evolysse/Estyme dermal filler expansion International/global expansion
Revenue
$61.00M*
▲ 39.8% YoY
Gross margin
63.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Evolus, Inc. (EOLS) Q3 2023 Earnings Call Transcript
Revenue
$50.02M
▲ 47.6% YoY
Diluted EPS
$-0.30
Gross margin
69.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Evolus, Inc. (EOLS) Q2 2023 Earnings Call Transcript
Revenue
$49.35M
▲ 32.8% YoY
Diluted EPS
$-0.32
Gross margin
70.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Evolus, Inc. (EOLS) Q1 2023 Earnings Call Transcript
Revenue
$41.72M
▲ 23% YoY
Diluted EPS
$-0.26
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-30
Evolus, Inc. (EOLS) Q4 2022 Earnings Call Transcript
Revenue
$43.65M*
▲ 25.9% YoY
Gross margin
62.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Evolus, Inc. (EOLS) Q3 2022 Earnings Call Transcript
Revenue
$33.90M
▲ 27.1% YoY
Diluted EPS
$-0.36
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Evolus, Inc. (EOLS) Q2 2022 Earnings Call Transcript
Revenue
$37.16M
▲ 42.4% YoY
Diluted EPS
$-0.42
Gross margin
57.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Evolus, Inc. (EOLS) Q1 2022 Earnings Call Transcript
Revenue
$33.91M
▲ 177% YoY
Diluted EPS
$-0.31
▼ 293.8% YoY
Gross margin
61.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Evolus, Inc. (EOLS) Q4 2021 Earnings Call Transcript
Revenue
$34.66M*
▲ 68.4% YoY
Gross margin
54.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Evolus, Inc. (EOLS) Q3 2021 Earnings Call Transcript
Revenue
$26.68M
▲ 51.1% YoY
Diluted EPS
$-0.35
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Evolus, Inc. (EOLS) Q2 2021 Earnings Call Transcript
Revenue
$26.10M
▲ 234.3% YoY
Diluted EPS
$-0.31
Gross margin
56.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-26
Evolus, Inc. (EOLS) Q1 2021 Earnings Call Transcript
Revenue
$12.24M
▲ 16.6% YoY
Diluted EPS
$0.16
Gross margin
59.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-05
Evolus, Inc. (EOLS) Q4 2020 Earnings Call Transcript
Revenue
$20.58M*
▲ 5.8% YoY
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Evolus, Inc. (EOLS) Q3 2020 Earnings Call
Revenue
$17.66M
▲ 34.1% YoY
Diluted EPS
$-0.34
Gross margin
72.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Evolus, Inc. (EOLS) Q2 2020 Earnings Call Transcript
Revenue
$7.81M
▲ 237.8% YoY
Diluted EPS
$-0.63
Gross margin
75.0%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
Evolus, Inc. (EOLS) Q1 2020 Earnings Call Transcript
Revenue
$10.50M
Diluted EPS
$-0.59
Gross margin
59.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Evolus, Inc. (EOLS) Q4 2019 Earnings Call
Revenue
$19.45M*
Gross margin
81.3%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–31 of 31 webcasts
Key facts CIK 1570562 CUSIP 30052C107 13F (30d) 32 filings 32 filers Visit website Investor relations